This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Buy These 5 Low-Leverage Stocks Amid Tariff-Induced Uncertainty
by Aparajita Dutta
Amid market jitters and tariff threats, low-leverage picks like NWG, ZION, INGR, KINS and LXFR offer safer growth potential.
Are Investors Undervaluing Kingstone Companies (KINS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Kingstone's Reinsurance Program: Why it is a Cornerstone of Growth
by Tanuka De
KINS boosts its catastrophe reinsurance limit by 57% with minimal cost impact, fueling capital efficiency and premium growth.
Kingstone's Policy Growth Steady: Will it Fuel Premium Acceleration?
by Tanuka De
KINS rides on new policies and premium growth as rivals exit key markets, aiming for stronger profits in 2025.
Kingstone Companies Stock Down 3% YTD: Should You Buy the Dip?
by Tanuka De
KINS stock lags the market YTD, but strong 2025 earnings guidance and margin gains point to a turnaround in motion.
KINS Focuses on Personal Lines Business: Will This Accelerate Growth?
by Tanuka De
KINS sharpens its focus on personal lines, digital tools and underwriting discipline to drive regional growth.
Kingstone Returns to Profitability: Can It Retain the Momentum?
by Tanuka De
KINS returns to profit with a 1610 bps net margin boost and eyes growth as rivals exit the personal property space.
KINS vs. UFCS: Which Regional Insurer Offers Better Value Investment?
by Tanuka De
KINS and UFCS both show promise, but let's see which insurer offers stronger growth and better value in a changing P&C market?
KINS Trades at a Premium to Industry: Will You Still Buy the Stock?
by Tanuka De
KINS' focus on growing its core business, strengthening its niche market, improving pricing and combined ratio and expanding margins bodes well for growth.
Zacks.com featured highlights include Nomad Foods, DXP Enterprises, Great Lakes Dredge & Dock and Kingstone
by Zacks Equity Research
Nomad Foods, DXP Enterprises, Great Lakes Dredge & Dock and Kingstone are part of the Zacks Screen of the Week article.
Solid Cash Flow Growth Makes These 4 Stocks Worth Buying Now
by Moumita C. Chattopadhyay
Cash indicates a company's true financial health. So, companies with rising cash flows like NOMD, DXPE, GLDD and KINS are worth buying.
Buy These 5 Low-Leverage Stocks Amid Easing U.S.-China Trade Tension
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt. You may buy SRCE, KINS, MTZ, DORM and STRL.
AIG Q1 Earnings Top on New Business Despite High Catastrophe Loss
by Zacks Equity Research
AIG returns $2.4 billion to shareholders in the first quarter via share buybacks and dividends.
Aflac Q1 Earnings Miss Estimates on Lower Japan Premiums
by Zacks Equity Research
AFL continues to witness growth in U.S. segment revenues. It returns $900 million to shareholders in the first quarter via share buybacks.
RenaissanceRe Q1 Earnings Miss on High Expenses & California Wildfires
by Zacks Equity Research
RNR continues to witness growth in net premiums earned from the property segment.
Recent Price Trend in Kingstone Companies (KINS) is Your Friend, Here's Why
by Zacks Equity Research
Kingstone Companies (KINS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Buy These 5 Low-Leverage Stocks to Counter Market Volatility
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt. You can buy BILI, KINS, ENGIY, ASML and RMD.
Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI
by Zacks Equity Research
Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI are part of the Zacks Screen of the Week article.
5 Stocks With Recent Price Strength Amid Tariff-Led Volatility
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are HRTG, MRX, KINS, ANIP, HCI.
KINS vs. KNSL: Which Excess & Surplus Insurer Should You Bet On?
by Tanuka De
Let's find out which insurer is a safe investment option, KINS or KNSL.
Zacks.com featured highlights include Griffon, DXP Enterprises, Willdan and Kingstone
by Zacks Equity Research
Griffon, DXP Enterprises, Willdan and Kingstone have been highlighted in this Screen of The Week article.
Forget Profit, Bet on 4 Stocks With Increasing Cash Flows
by Moumita C. Chattopadhyay
Cash gives a company vitality and strength and can indeed be referred to as its lifeblood. So, GFF, DXPE, WLDN and KINS, with rising cash flows, are worth buying.
Zacks.com featured highlights Griffon, BGC, Kingstone and Sterling Infrastructure
by Zacks Equity Research
Griffon, BGC, Kingstone and Sterling Infrastructure have been highlighted in this Screen of The Week article.
Grab These 4 Stocks With Solid Net Profit Margins to Boost Returns
by Anirudha Bhagat
Buy these four top-ranked stocks, GFF, BGC, KINS and STRL, with solid net profit margins to enhance your portfolio returns.
Kingstone Companies (KINS) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Kingstone Companies (KINS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.